VKH
NVCR icon

Virtu KCG Holdings’s NovoCure NVCR Stock Holding History

Virtu KCG Holdings’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$630K Buy
+36,424
New +$470K 0.02% 932
2017
Q1 		– Sell
-10,100
Closed -$79K – 3550
2016
Q4 		$79K Buy
+10,100
New +$81.2K ﹤0.01% 2989

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Virtu KCG Holdings's NVCR Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in NovoCure (NVCR) in Q2 2017: 36,424 shares worth $630K. The stake represents 0.02% of the portfolio and ranks #932 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in NVCR as recently as Q4 2016.

Virtu KCG Holdings first reported a position in NVCR in Q4 2016 and has held it in 2 quarters since. 85 funds tracked by Wall St. Rank hold NVCR as of Q2 2017.

  • Virtu KCG Holdings held 36,424 shares of NovoCure worth $630K as of Q2 2017.
  • NovoCure was a new Virtu KCG Holdings position in Q2 2017.
  • NovoCure made up 0.02% of Virtu KCG Holdings's portfolio in Q2 2017, its #932 holding.
  • Virtu KCG Holdings first reported a position in NovoCure in Q4 2016 and has held it in 2 quarters since.
  • 85 funds tracked by Wall St. Rank held NovoCure as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.